-
TRUSTED AU LABORATORY
-
26 Mark Rd. Elizabeth South, SA - 5112
-
Same day delivery
Pull the syringe to:
(0.100ml)
This calculator is provided as a reference tool for research purposes only. Always follow your institution’s safety protocols when handling research compounds.
5-Amino-1MQ 50mg is a synthetic small-molecule research compound studied in relation to nicotinamide N-methyltransferase inhibition, NAD+ pathway research, methylation biology, adipocyte metabolism and broader metabolic research models.
Although it may appear in peptide research catalogues, 5-Amino-1MQ is not a peptide. It is more accurately described as a small-molecule NNMT inhibitor. PubChem lists 5-Amino-1-methylquinolinium with the molecular formula C10H11N2+ and identifies it as a quinolinium compound.
This product is supplied for laboratory research use only. It is not a medicine, supplement, weight loss product, metabolic treatment, longevity product, NAD+ booster, body composition product or injectable product for human use.
| Product Detail | Information |
|---|---|
| Product name | 5-Amino-1MQ |
| Full chemical name | 5-Amino-1-methylquinolinium |
| Common research names | 5A1MQ, 5-amino-1MQ, NNMT inhibitor |
| Size | 50mg |
| Product type | Small-molecule research compound |
| Research category | Metabolic Research / NAD+ Pathway Research |
| Common research interest | NNMT inhibition, NAD+ metabolism, methylation biology, adipocyte research |
| Main target interest | Nicotinamide N-methyltransferase, also known as NNMT |
| Form | Research powder or supplier-specific preparation |
| Intended use | Laboratory research only |
| Human use | Not for human consumption, administration, weight loss or injection |
| Documentation | Certificate of Analysis should be checked before use |
| Component | Research Class | General Research Role |
| 5-Amino-1MQ | Synthetic small-molecule compound | Studied as an NNMT inhibitor in metabolic and methylation research |
| 5-Amino-1-methylquinolinium | Quinolinium research compound | Used as the full chemical name for 5-Amino-1MQ |
| NNMT inhibitor activity | Enzyme inhibition research | Studied in relation to nicotinamide metabolism and methyl donor pathways |
| Molecular formula | C10H11N2+ | Listed by PubChem for the 5-Amino-1-methylquinolinium ion |
| Salt form | Supplier-specific | Must be confirmed through CoA, SDS and product documentation |
| Dry research preparation | Supplier-specific research format | Supports storage before laboratory preparation when stored correctly |
Product identity, purity, salt form, molecular weight and batch information should always be confirmed through supplier documentation and the Certificate of Analysis. Researchers should not rely on the product name alone because 5-Amino-1MQ may be supplied in different salt forms.
5-Amino-1MQ is studied as an inhibitor of nicotinamide N-methyltransferase, commonly shortened to NNMT. NNMT is an enzyme involved in nicotinamide metabolism and methyl donor biology.
In simplified research terms, NNMT uses S-adenosylmethionine, also known as SAM, to methylate nicotinamide and produce 1-methylnicotinamide. Because this reaction connects nicotinamide metabolism with methylation biology, NNMT has become a research target in studies involving NAD+ availability, SAM balance, adipocyte metabolism and metabolic disease models.
A Scientific Reports study examined 5-amino-1-methylquinolinium as an NNMT inhibitor in diet-induced obese mice and reported that combining NNMT inhibition with a low-fat diet changed whole-body adiposity and weight outcomes in that preclinical mouse model. This should be treated as animal research context only, not as a human weight loss claim.
| Research Area | 5-Amino-1MQ |
| Main research category | NNMT inhibitor research |
| Product class | Small-molecule research compound |
| Main enzyme interest | Nicotinamide N-methyltransferase |
| Pathway interest | NAD+ metabolism, nicotinamide metabolism and methyl donor biology |
| Methylation interest | SAM, SAH and methylation pathway research |
| Metabolic interest | Adipocyte biology, energy expenditure and metabolic pathway models |
| Evidence limitation | Mostly preclinical and laboratory research |
| Product limitation | Research use only, not approved for human use |
| Feature | 5-Amino-1MQ | Peptide-Based Metabolic Products |
| Product class | Small-molecule compound | Peptide or peptide analogue |
| Main research target | NNMT enzyme | Usually receptor or hormone pathway |
| Common pathway | NAD+, nicotinamide and methylation metabolism | GLP-1, GIP, GHRH, hGH fragment or mitochondrial pathways |
| Structure | Quinolinium-style small molecule | Amino acid chain or modified peptide |
| Solvent planning | Must be confirmed by CoA, SDS and protocol | Often peptide-style diluent planning, depending on product |
| Human-use claim | Not appropriate | Not appropriate for research-use products |
| Feature | 5-Amino-1MQ | AOD-9604 |
| Research class | Small-molecule NNMT inhibitor | hGH fragment research peptide |
| Main research target | NNMT enzyme | Human growth hormone fragment pathway |
| Common research interest | NAD+, SAM, methylation and adipocyte metabolism | Lipolysis pathway and adipocyte research |
| Product type | Not a peptide | Peptide fragment |
| Common SEO risk | Being marketed as a fat loss or NAD+ product | Being marketed as a fat loss peptide |
| Safer positioning | NNMT inhibitor research compound | hGH fragment research peptide |
| Strength | Product Page Positioning |
| 5-Amino-1MQ 5mg | Small research amount for protocol-specific screening |
| 5-Amino-1MQ 10mg | Lower-volume research vial for laboratory assay planning |
| 5-Amino-1MQ 25mg | Mid-size research amount for protocol-specific concentration planning |
| 5-Amino-1MQ 50mg | Higher research amount for laboratory concentration planning |
| 5-Amino-1MQ 100mg | Larger research supply where supported by protocol and documentation |
Different amounts should be treated as product variants, not separate therapeutic claims. If multiple strengths are listed separately, each page should have a strength-specific title, meta description, slug, concentration table and internal links to reduce SEO cannibalisation.
| Common Online Claim | Safer Research-Use Wording |
| Fat loss | Studied in adipocyte metabolism and diet-induced obesity research models |
| Weight loss | Studied in preclinical mouse models, not an approved human-use claim |
| NAD+ booster | Better framed as NAD+ pathway and nicotinamide metabolism research |
| Anti-ageing | Not an approved or appropriate product claim |
| Energy support | Better framed as cellular metabolism and enzyme pathway research |
| Appetite control | Not the main research positioning and not an approved claim |
| Body recomposition | Not an approved or appropriate product claim |
| Metabolic treatment | Not an approved or appropriate product claim |
5-Amino-1MQ 50mg is not intended to diagnose, treat, cure or prevent any disease. It is not supplied for fat loss, weight loss, NAD+ boosting, anti-ageing, metabolic health, appetite control, body transformation, bodybuilding, energy enhancement, performance enhancement or general wellness use.
All information on this page is provided for laboratory research and product handling context only.
There is no universal recommended dilution for 5-Amino-1MQ 50mg. Dilution depends on the research protocol, required working concentration, assay design, solvent compatibility, salt form, storage method and validated laboratory procedure.
Because 5-Amino-1MQ is a small-molecule compound rather than a peptide, researchers should not assume peptide-style reconstitution methods or water-based preparation methods are suitable. Solvent compatibility should be confirmed through the supplier Certificate of Analysis, SDS and validated research protocol.
For research concentration planning only, the basic formula is:
Total compound amount divided by solvent volume equals final concentration.
| Solvent Added to 50mg Vial | Final Concentration |
| 1mL | 50mg/mL |
| 2mL | 25mg/mL |
| 5mL | 10mg/mL |
| 10mL | 5mg/mL |
| 20mL | 2.5mg/mL |
| 25mL | 2mg/mL |
| 50mL | 1mg/mL |
These are research concentration examples only. They are not human dosing instructions and must not be used to calculate injection quantities.
Before handling 5-Amino-1MQ 50mg in a laboratory setting, make sure all materials, documentation and clean handling conditions are prepared.
| Item | Purpose |
| Product vial | Contains 5-Amino-1MQ research compound |
| Certificate of Analysis | Confirms batch-level testing information |
| SDS or safety documentation | Provides hazard, handling and disposal guidance |
| Suitable research-grade solvent | Used to prepare a working laboratory solution if compatible |
| Sterile or clean lab consumables | Helps reduce contamination and cross-contamination risk |
| Personal protective equipment | Gloves, lab coat and eye protection |
| Approved disinfectant | Used for bench and handling area preparation |
| Laboratory labels | Records concentration, date, batch and handler details |
| Controlled storage access | Supports correct storage after preparation |
| Chemical waste container | Used for compliant laboratory waste disposal |
The following is a general laboratory handling framework only. Always follow the product Certificate of Analysis, supplier documentation, SDS, institutional procedures and validated research protocol.
Check the product label, batch number, Certificate of Analysis, SDS and storage requirements before handling the vial.
Use a clean laboratory workspace suitable for handling small-molecule research compounds. Wear appropriate PPE and disinfect the bench surface and required equipment.
Do not assume 5-Amino-1MQ is compatible with the same diluent used for peptides. Confirm the required research-grade solvent or vehicle through supplier documentation, SDS and the approved research protocol.
Add the selected research-grade solvent according to laboratory procedure. Avoid uncontrolled splashing, aerosol generation or unnecessary exposure.
Gently swirl, invert or mix according to the validated protocol until the compound is dissolved or suspended as required. Do not heat, sonicate or vortex unless the protocol specifically allows it.
Check the preparation for visible particles, cloudiness, unexpected precipitation, unusual colour changes or separation. If anything appears abnormal, quarantine the preparation and check supplier documentation.
Label the vial or aliquots with the product name, concentration, solvent used, date prepared, batch number and researcher initials.
Place the prepared solution into the required storage condition as soon as possible. Avoid unnecessary temperature cycling, light exposure or repeated freeze-thaw cycles.
Some small-molecule research compounds may not dissolve easily in water or peptide-style diluents. Solubility should always be handled according to validated laboratory protocol.
| Issue | What It May Indicate | Safer Response |
| Powder remains after mixing | Solvent may not be suitable | Check SDS and supplier solubility guidance |
| Cloudiness appears | Incomplete dissolution or incompatibility | Stop and review protocol |
| Precipitation occurs | Concentration may be too high or solvent unsuitable | Reassess working concentration and solvent |
| Colour change | Possible degradation or contamination | Do not continue without supplier guidance |
| Separation occurs | Vehicle incompatibility | Quarantine and review documentation |
| Storage Factor | Guidance |
| Product form | Dry research compound or supplier-specific preparation |
| Storage condition | Follow supplier label, CoA and SDS |
| Light exposure | Protect from unnecessary light exposure |
| Moisture exposure | Keep sealed until use |
| Temperature changes | Avoid repeated temperature cycling |
| Handling | Minimise unnecessary opening and exposure |
| Storage Factor | Guidance |
| Storage condition | Follow validated research protocol |
| Labelling | Record concentration, solvent, date and batch number |
| Freeze-thaw cycles | Avoid repeated freeze-thaw exposure where relevant |
| Aliquoting | Use small research aliquots where appropriate |
| Contamination control | Use clean laboratory technique |
| Light exposure | Protect from unnecessary light exposure if required |
| Disposal | Dispose according to chemical waste procedures |
Small-molecule research compounds may be sensitive to temperature, light, solvent conditions and contamination. Storage conditions should be confirmed through supplier documentation or the laboratory’s validated method.
This page does not provide human dosing, injection instructions, injection schedules or administration guidance.
5-Amino-1MQ 50mg is not supplied for human or animal administration. It is a laboratory research-use product only.
For research settings, any measured aliquots should be prepared according to the concentration required by the approved research protocol. All calculations should be checked, documented and traceable.
| Planning Item | What to Record |
| Final concentration | Total compound amount and solvent volume |
| Working solution | Concentration used in the research protocol |
| Aliquot volume | Volume transferred into each labelled lab container |
| Batch details | Product batch, CoA and preparation date |
| Solvent or vehicle | Exact solvent, percentage and preparation method |
| Salt form | Confirmed salt form from CoA or supplier documentation |
| Storage location | Fridge, freezer, desiccator or other controlled storage area |
| Handler details | Researcher name or initials |
| Preparation date | Date and time of preparation |
| Disposal date | When the aliquot should no longer be used |
| Strength check | Confirmation that the 50mg amount matches the approved research protocol |
Correct handling is important for research consistency, contamination control, chemical safety and product traceability. Most mistakes occur when products are not labelled clearly, solvent compatibility is assumed, concentration calculations are not recorded or storage conditions are not followed.
Because 5-Amino-1MQ is often promoted online around fat loss, NAD+ and metabolic enhancement, product pages should avoid wording that could be interpreted as encouraging human weight loss, self-use, anti-ageing, injection or supplementation.
| Always | Why It Matters |
| Check the Certificate of Analysis | Confirms batch-level information |
| Review the SDS | Supports safe chemical handling and disposal |
| Confirm the salt form | Helps avoid incorrect concentration or molar calculations |
| Use PPE | Reduces exposure and contamination risk |
| Confirm solvent compatibility | Prevents failed preparation or invalid research results |
| Label every vial and aliquot | Prevents mix-ups |
| Record concentration calculations | Supports traceability |
| Use clean laboratory technique | Reduces contamination risk |
| Follow institutional protocols | Keeps handling consistent and auditable |
| Store according to documentation | Helps protect compound integrity |
| Dispose of chemical waste correctly | Supports safety and compliance |
| Use research-use wording only | Reduces misleading human-use interpretation |
| Never | Why It Is Risky |
| Never use for self-injection | Product is research use only |
| Never sell or promote as a fat loss product | Creates human-use and compliance risk |
| Never make weight loss claims | Not an approved or appropriate product claim |
| Never market it as an NAD+ booster | Misleading for a research-use compound |
| Never make anti-ageing claims | Not an approved or appropriate product claim |
| Never assume peptide handling applies | 5-Amino-1MQ is not a peptide |
| Never assume water solubility | Solvent compatibility depends on product form and protocol |
| Never assume salt form without documentation | Concentration and molecular calculations may be wrong |
| Never assume purity without CoA | Batch quality must be documented |
| Never use a damaged or unlabelled vial | Identity and integrity may be uncertain |
| Never use random solvents | May damage the compound or invalidate research results |
| Never leave prepared solutions unlabelled | Creates traceability risk |
| Never rely on social media protocols | They may be inaccurate, unsafe or non-compliant |
The table below is for concentration planning only. It does not represent dosage, injection quantity or recommended administration.
| Total Vial Amount | Solvent Volume | Final Concentration |
| 50mg | 1mL | 50mg/mL |
| 50mg | 2mL | 25mg/mL |
| 50mg | 5mL | 10mg/mL |
| 50mg | 10mL | 5mg/mL |
| 50mg | 20mL | 2.5mg/mL |
| 50mg | 25mL | 2mg/mL |
| 50mg | 50mL | 1mg/mL |
If a researcher adds 10mL of a suitable validated research solvent to a 50mg vial, the resulting concentration is 5mg/mL.
This calculation is for research concentration planning only. It is not a human or animal dosing example.
5-Amino-1MQ is a synthetic small-molecule research compound also known as 5-Amino-1-methylquinolinium. It is studied as an NNMT inhibitor in metabolic, methylation and NAD+ pathway research.
No. 5-Amino-1MQ may be listed in peptide catalogues, but it is not a peptide. It is a small-molecule quinolinium research compound.
5-Amino-1MQ is studied in relation to nicotinamide N-methyltransferase, also known as NNMT. NNMT links nicotinamide metabolism with methyl donor biology.
5-Amino-1MQ is studied because NNMT activity is connected to nicotinamide metabolism, NAD+ pathway availability, SAM usage, methylation biology and adipocyte metabolic models.
No. This research product is not approved or supplied for weight loss, fat loss, metabolic treatment, NAD+ boosting, anti-ageing or human use. It should be described only as a laboratory research product.
No. 5-Amino-1MQ is a small-molecule NNMT inhibitor. AOD-9604 is a human growth hormone fragment research peptide, while Retatrutide is a triple receptor agonist research peptide. These products belong to different research classes.
Not automatically. 5-Amino-1MQ is not a peptide, so solvent compatibility, salt form and preparation method should be confirmed through the CoA, SDS and laboratory protocol.
A Certificate of Analysis provides batch-level testing information. It helps researchers verify product identity, purity, salt form and quality documentation before use in a research setting.
| Resource | Why It Is Useful |
| PubChem 5-Amino-1-methylquinolinium profile | Useful background on compound identity, chemical naming and molecular formula. |
| Scientific Reports NNMT inhibition study | Useful preclinical background on 5-amino-1-methylquinolinium in diet-induced obese mouse models. |
| Sigma-Aldrich 5-Amino-1MQ technical listing | Useful supplier-level reference for NNMT inhibitor positioning and CoA-style documentation context. |
Research Use Only: 5-Amino-1MQ 50mg is supplied strictly for laboratory research purposes. It is not intended for human or animal consumption, injection, therapeutic use, cosmetic use, diagnostic use, fat loss, weight loss, NAD+ boosting, metabolic treatment, anti-ageing, body enhancement, bodybuilding or performance enhancement. Information on this page is provided for research education and product handling context only. Always follow applicable laws, institutional procedures, supplier documentation, SDS guidance and qualified laboratory protocols.
